Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts



Related Series

Enterprise Physician Scheduling 2021
Enterprise Scheduling

 End chart zoom
Enterprise Scheduling 2007 Market Review Enterprise Scheduling 2007 Market Review
* A page refresh may be necessary to see the updated image

Enterprise Scheduling 2007 Market Review

April 20, 2007

Implementing Enterprise Scheduling is a significant project. It requires workflow redesign and interaction with registration and ADT, revenue cycle intake, clinical treatment planning, order entry, and case management. As an application, it presents one of the most complex interface and integration planning challenges and ongoing maintenance that is daunting. These applications are expensive to design, develop, test, and deliver for the vendors and are similarly a large investment on the part of the healthcare providers to select, implement, test, train, and maintain.

This report includes a total of 10 products from 10 vendors. There are six products that qualify to be in the Main Body of the report and four that qualify for the Early Data section:

Main Body vendors (research collected includes at least 15 unique organizations) include:

  • Cerner Scheduling Management
  • Epic Cadence Scheduling
  • McKesson Pathways Healthcare Scheduling v.8-10
  • QuadraMed Tempus TempusOne
  • SCI Solutions Schedule Maximizer

Early data vendors (research collected includes at least six unique organizations) include:

  • CQI Care Tracker – Enterprise
  • Per-Se One-Call
  • Siemens Soarian Scheduling
  • StatSchedules StratScheduler
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.